Paper2665645
Ceftriaxone-netilmicin combination in single-daily-dose treatment of experimental Escherichia coli endocarditis.
Fantin B and 6 others. Antimicrob Agents Chemother, 1989. Cited by 37 papers, by iCite.
Cite this record
ConductScience Library. Ceftriaxone-netilmicin combination in single-daily-dose treatment of experimental Escherichia coli endocarditis. Papers, record 2665645. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2665645
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Ceftriaxone-netilmicin combination in single-daily-dose treatment of experimental Escherichia coli endocarditis.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ceftriaxone | Major topic |
| Endocarditis, Bacterial | Major topic |
| Escherichia coli Infections | Major topic |
| Netilmicin | Major topic |
| Animals | |
| Drug Combinations | |
| Female | |
| Half-Life | |
| Humans | |
| Male | |
| Rabbits |
Source PubMed
References12
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6093513 | Pharmacokinetic profile of ceftriaxone in man. | Am J Med | 1984 | https://conductscience.org/library/papers/6093513 | PubMed |
| 2 | 4091526 | Comparison of penicillin and vancomycin, individually and in combination with gentamicin and amikacin, in the treatment of experimental endocarditis induced by nutritionally variant streptococci. | Antimicrob Agents Chemother | 1985 | https://conductscience.org/library/papers/4091526 | PubMed |
| 3 | 3516963 | Kinetics and bactericidal effect of gentamicin and latamoxef (moxalactam) in experimental Escherichia coli endocarditis. | J Antimicrob Chemother | 1986 | https://conductscience.org/library/papers/3516963 | PubMed |
| 4 | 3540140 | Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. | J Infect Dis | 1987 | https://conductscience.org/library/papers/3540140 | PubMed |
| 5 | 3300530 | Comparative efficacy of cefotiam, cefmenoxime, and ceftriaxone in experimental endocarditis and correlation with pharmacokinetics and in vitro efficacy. | Antimicrob Agents Chemother | 1987 | https://conductscience.org/library/papers/3300530 | PubMed |
| 6 | 6795989 | Minimal concentrations of aminoglycoside that can synergize with penicillin in enterococcal endocarditis. | Antimicrob Agents Chemother | 1981 | https://conductscience.org/library/papers/6795989 | PubMed |
| 7 | 3324957 | Value of antibiotic levels in serum and cardiac vegetations for predicting antibacterial effect of ceftriaxone in experimental Escherichia coli endocarditis. | Antimicrob Agents Chemother | 1987 | https://conductscience.org/library/papers/3324957 | PubMed |
| 8 | 3134490 | The influence of tobramycin dosage regimens on nephrotoxicity, ototoxicity, and antibacterial efficacy in a rat model of subcutaneous abscess. | J Infect Dis | 1988 | https://conductscience.org/library/papers/3134490 | PubMed |
| 9 | 3392422 | Single, large, daily dosing versus intermittent dosing of tobramycin for treating experimental pseudomonas pneumonia. | J Infect Dis | 1988 | https://conductscience.org/library/papers/3392422 | PubMed |
| 10 | 2971498 | Tolerance of once-daily dosing of netilmicin and teicoplanin, alone or in combination, in healthy volunteers. | Clin Pharmacol Ther | 1988 | https://conductscience.org/library/papers/2971498 | PubMed |
| 11 | 512417 | The influence of dosage regimen on experimental gentamicin nephrotoxicity: dissociation of peak serum levels from renal failure. | J Infect Dis | 1979 | https://conductscience.org/library/papers/512417 | PubMed |
| 12 | 3121761 | In vivo postantibiotic effect in a thigh infection in neutropenic mice. | J Infect Dis | 1988 | https://conductscience.org/library/papers/3121761 | PubMed |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 25210404 | Netilmicin-induced carpopedal spasm. | J Pharmacol Pharmacother | 2014 | https://conductscience.org/library/papers/25210404 | PubMed |
| 24587365 | Beneficial antimicrobial effect of the addition of an aminoglycoside to a β-lactam antibiotic in an E. coli porcine intensive care severe sepsis model. | PLoS One | 2014 | https://conductscience.org/library/papers/24587365 | PubMed |
| 23807657 | Antimicrobial treatment of febrile neutropenia: pharmacokinetic-pharmacodynamic considerations. | Clin Pharmacokinet | 2013 | https://conductscience.org/library/papers/23807657 | PubMed |
| 10223909 | Effectiveness and toxicity of gentamicin in an experimental model of pyelonephritis: effect of the time of administration. | Antimicrob Agents Chemother | 1999 | https://conductscience.org/library/papers/10223909 | PubMed |
| 8878597 | Synergy between amoxicillin and gentamicin in combination against a highly penicillin-resistant and -tolerant strain of Streptococcus pneumoniae in a mouse pneumonia model. | Antimicrob Agents Chemother | 1996 | https://conductscience.org/library/papers/8878597 | PubMed |
| 8851618 | Temporal variation in nephrotoxicity of low doses of isepamicin in rats. | Antimicrob Agents Chemother | 1996 | https://conductscience.org/library/papers/8851618 | PubMed |
| 8452350 | Synergistic activity of ceftriaxone combined with netilmicin administered once daily for treatment of experimental streptococcal endocarditis. | Antimicrob Agents Chemother | 1993 | https://conductscience.org/library/papers/8452350 | PubMed |
| 8239615 | Simulated human serum profiles of one daily dose of ceftriaxone plus netilmicin in treatment of experimental streptococcal endocarditis. | Antimicrob Agents Chemother | 1993 | https://conductscience.org/library/papers/8239615 | PubMed |
| 8031041 | Ceftriaxone protects against tobramycin nephrotoxicity. | Antimicrob Agents Chemother | 1994 | https://conductscience.org/library/papers/8031041 | PubMed |
| 2188586 | Activity of sulbactam in combination with ceftriaxone in vitro and in experimental endocarditis caused by Escherichia coli producing SHV-2-like beta-lactamase. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/2188586 | PubMed |
| 2128443 | Importance of the aminoglycoside dosing regimen in the penicillin-netilmicin combination for treatment of Enterococcus faecalis-induced experimental endocarditis. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/2128443 | PubMed |
| 2014965 | Impact of dosage schedule on the efficacy of gentamicin, tobramycin, or amikacin in an experimental model of Serratia marcescens endocarditis: in vitro-in vivo correlation. | Antimicrob Agents Chemother | 1991 | https://conductscience.org/library/papers/2014965 | PubMed |
| 1759831 | Single daily dosing of antibiotics: importance of in vitro killing rate, serum half-life, and protein binding. | Antimicrob Agents Chemother | 1991 | https://conductscience.org/library/papers/1759831 | PubMed |
| 1510412 | In vivo antibiotic synergism: contribution of animal models. | Antimicrob Agents Chemother | 1992 | https://conductscience.org/library/papers/1510412 | PubMed |
| 1444286 | Pharmacokinetic and pharmacodynamic requirements for antibiotic therapy of experimental endocarditis. | Antimicrob Agents Chemother | 1992 | https://conductscience.org/library/papers/1444286 | PubMed |
| 1329634 | Piperacillin, tazobactam, and gentamicin alone or combined in an endocarditis model of infection by a TEM-3-producing strain of Klebsiella pneumoniae or its susceptible variant. | Antimicrob Agents Chemother | 1992 | https://conductscience.org/library/papers/1329634 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2665645
GET https://conductscience.org/api/papers/v1/2665645/authors